| |
| Magyar Ortopéd Társaság |
|
| 16. Európai Szövetbankkongresszus - 16th International Congress of the European Association of Tissue Banks |
 Rendezvény kezdete: 2007.10.17. | Rendezvény vége: 2007.10.20. |
| Szervező: Congress Secretariat |
| Munkahely neve: Asszisztencia Szervező Kft. |
| Címe: 1136 Budapest, Hegedus Gy. u. 20. |
| Tel: +36 1 350 1854 |
| Fax: +36 1 350 0929 |
| E-mail: eatb@asszisztencia.hu |
| Helyszín: 1113 Budapest, DANUBIUS HOTEL FLAMENCO****, Tas vezér u. 3-7. |
| A rendezvény Web oldala: http://www.asszisztencia.hu/eatb |
Important Dates:
May 18, 2007:
2nd Announcement and call for abstracts
August 31, 2007:
Deadline for abstract submission
September 15, 2007:
Deadline for abstract evaluation
August 31, 2007:
Deadline for early registration
September 17, 2007:
Deadline for hotel reservation and payment
October 15, 2007:
Deadline for standard registration
|
|
|
 |
| |
| Magyar Kardiológusok Társasága |
|
| International Conference on Early Disease Detection and Prevention (EDDP) |
| Rendezvény kezdete: 2010.02.25. | Rendezvény vége: 2010.02.28. |
| Helyszín: Németország, München, |
| A rendezvény Web oldala: http://www.paragon-conventions.com/EDDP2010 |
This year's EDDP conference will focus on cardiovascular (cardiac disease and hypertension), metabolic (diabetes) and renal diseases. With a scientific program featuring a distinguished international panel of leading speakers, as well as a concurrent exhibition, this conference aims to:
Discuss all elements relevant to early detection of disease prior to its clinical appearance
Highlight the most updated technological and other means for disease prevention
Encourage a free exchange of ideas among high-caliber presenters and participants
Serve as a platform for the biotech/pharma industries to discuss ongoing projects and products
Present general principles, ongoing academic/industrial research, and the latest achievements in the field
Highlight biotechnological innovations and evaluate their applicability and cost-effectiveness
Set the stage for prevention of disease by pharmacological, genetic or other interventional modalities |
|
|
|
